Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equivalence trial of icodextrin peritoneal dialysis solution in ESRD patients undergoing CAPD with one daily long dwell
CTR20262465Phase 3Active
- Sponsor
- Liteng Pharma
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of icodextrin in end-stage kidney disease (ESKD), sponsored by Liteng Pharma. Started Jun 2026; status: active.
02
Drugs
icodextrin
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on CTR20262465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262465.